NASDAQ:BCRX

Biocryst Pharmaceuticals Stock Insider Trading

etoro logo Buy BCRX
*Your capital is at risk
$9.31
+0.170 (+1.86%)
At Close: Jun 23, 2026

BioCryst Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -12.30. In total, the insiders bought 5.78M and sold 1.09M BCRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-12.30
Buy 5.78M shares
Sell 1.09M shares
80% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
May 13, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 17, 2026
Buy
Emp. Stock Option (Right to Buy)
Dullinger Ronald
Chief Commercial Officer
Officer 255 050
Value: $1.82M
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Heggie Theresa
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Stonehouse Jon P
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Stonehouse Jon P
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Common Stock
A-Award
Milano Vincent
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Milne Jill C.
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Milne Jill C.
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Galson Steven K
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Galson Steven K
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Common Stock
A-Award
Levin Alan G
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Levin Alan G
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Frank Steven
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Frank Steven
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Sanders Machelle
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Sanders Machelle
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Milano Vincent
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Mckee Amy E
Director
Director 15 294
Value: $130.0K
Jun 11, 2026
Buy
Automatic Stock Option Grant
A-Award
Mckee Amy E
Director
Director 33 540
Value: $285.1K
Jun 11, 2026
Buy
Common Stock
A-Award
Heggie Theresa
Director
Director 15 294
Value: $130.0K
May 29, 2026
Buy
Common Stock
A-Award
Milne Jill C.
Director
Director 1 262
Value: $11.2K
May 29, 2026
Buy
Common Stock
A-Award
Stonehouse Jon P
Director
Director 631
Value: $6K
May 29, 2026
Buy
Common Stock
A-Award
Mckee Amy E
Director
Director 631
Value: $6K
May 29, 2026
Buy
Common Stock
A-Award
Milano Vincent
Director
Director 1 122
Value: $10K
May 29, 2026
Buy
Common Stock
A-Award
Frank Steven
Director
Director 1 262
Value: $11.2K
May 18, 2026
Sell
Common Stock
S-Sale
Mckee Amy E
Director
Director 11 180
Value: $100.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOCRYST PHARMACEUTICALS
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE